248 related articles for article (PubMed ID: 3325981)
41. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
[TBL] [Abstract][Full Text] [Related]
42. Babesia bovis: characterization of the T helper cell response against the 42-kDa merozoite surface antigen (MSA-1) in cattle.
Brown WC; Palmer GH; McElwain TF; Hines SA; Dobbelaere DA
Exp Parasitol; 1993 Aug; 77(1):97-110. PubMed ID: 8344411
[TBL] [Abstract][Full Text] [Related]
43. Detection of Babesia bigemina in cattle by a radioimmunoassay incorporating specifically depleted antigen.
Schuntner CA; Wright IG
Vet Parasitol; 1989 Jun; 31(3-4):229-41. PubMed ID: 2763443
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
Lawrence JA; Malika J; Whiteland AP; Kafuwa P
Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
[TBL] [Abstract][Full Text] [Related]
45. Viability after thawing and dilution of simultaneously cryopreserved vaccinal Babesia bovis and Babesia bigemina strains cultured in vitro.
Mangold AJ; Vanzini VR; Echaide IE; de Echaide ST; Volpogni MM; Guglielmone AA
Vet Parasitol; 1996 Feb; 61(3-4):345-8. PubMed ID: 8720572
[TBL] [Abstract][Full Text] [Related]
46. Identification and characterization of profilin antigen among Babesia species as a common vaccine candidate against babesiosis.
Munkhjargal T; Aboge GO; Ueno A; Aboulaila M; Yokoyama N; Igarashi I
Exp Parasitol; 2016 Jul; 166():29-36. PubMed ID: 27003460
[TBL] [Abstract][Full Text] [Related]
47. Cell-mediated immune responses to Babesia bovis merozoite antigens in cattle following infection with tick-derived or cultured parasites.
Brown WC; Logan KS; Wagner GG; Tetzlaff CL
Infect Immun; 1991 Jul; 59(7):2418-26. PubMed ID: 2050406
[TBL] [Abstract][Full Text] [Related]
48. Immunity following use of Australian tick fever vaccine: a review of the evidence.
Bock RE; de Vos AJ
Aust Vet J; 2001 Dec; 79(12):832-9. PubMed ID: 11837905
[TBL] [Abstract][Full Text] [Related]
49. The pathogenicity and immunologic relationship of a virulent and a tissue-culture-adapted Babesia bovis.
Kuttler KL; Zaugg JL; Yunker CE
Vet Parasitol; 1988 Mar; 27(3-4):239-44. PubMed ID: 3285573
[TBL] [Abstract][Full Text] [Related]
50. Prospects for recombinant vaccines against Babesia bovis and related parasites.
Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
[TBL] [Abstract][Full Text] [Related]
51. Babesia divergens vaccine.
Gorenflot A; Precigout E; Valentin A; Bissuel G; Carcy B; Brasseur P; Moreau Y; Schrevel J
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():279-81. PubMed ID: 1343703
[TBL] [Abstract][Full Text] [Related]
52. [Isolation of a field strain of Babesia bigemina (Piroplasma: Babesiidae) and establishment of in vitro culture for antigen production].
Rodríguez-Vivas RI; Quiñones-Avila FJ; Ramírez-Cruz GT; Cruz D; Wagner G
Rev Biol Trop; 2007 Mar; 55(1):127-33. PubMed ID: 18457120
[TBL] [Abstract][Full Text] [Related]
53. An update of the isolation and characterization of culture-derived soluble antigens of Babesia bovis.
James MA
Vet Parasitol; 1984 Jun; 14(3-4):231-7. PubMed ID: 6382780
[TBL] [Abstract][Full Text] [Related]
54. Antibody kinetics in response to vaccination against Babesia bovis.
James MA; Kuttler KL; Levy MG; Ristic M
Am J Vet Res; 1981 Nov; 42(11):1999-2001. PubMed ID: 7337297
[TBL] [Abstract][Full Text] [Related]
55. Immunochemical characterization of in vitro culture-derived antigens of Babesia bovis and Babesia bigemina.
Passos LM; Bell-Sakyi L; Brown CG
Vet Parasitol; 1998 Apr; 76(4):239-49. PubMed ID: 9650861
[TBL] [Abstract][Full Text] [Related]
56. Antigenic relationship between Plasmodium falciparum and Babesia bovis: reactivity with antibodies to culture-derived soluble exoantigens.
James MA; Montenegro-James S; Fajfar-Whetstone C; Montealegre F; Erickson J; Ristic M
J Protozool; 1987 Aug; 34(3):328-32. PubMed ID: 3309271
[TBL] [Abstract][Full Text] [Related]
57. Unravelling the cellular and molecular pathogenesis of bovine babesiosis: is the sky the limit?
Suarez CE; Alzan HF; Silva MG; Rathinasamy V; Poole WA; Cooke BM
Int J Parasitol; 2019 Feb; 49(2):183-197. PubMed ID: 30690089
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
Kuttler KL; Levy MG; James MA; Ristic M
Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
[TBL] [Abstract][Full Text] [Related]
59. Molecular and serological detection of Babesia bovis- and Babesia bigemina-infection in bovines and water buffaloes raised jointly in an endemic field.
Romero-Salas D; Mira A; Mosqueda J; García-Vázquez Z; Hidalgo-Ruiz M; Vela NA; de León AA; Florin-Christensen M; Schnittger L
Vet Parasitol; 2016 Feb; 217():101-7. PubMed ID: 26827869
[TBL] [Abstract][Full Text] [Related]
60. Development of a rapid immunochromatographic test for simultaneous serodiagnosis of bovine babesioses caused by Babesia bovis and Babesia bigemina.
Kim CM; Blanco LB; Alhassan A; Iseki H; Yokoyama N; Xuan X; Igarashi I
Am J Trop Med Hyg; 2008 Jan; 78(1):117-21. PubMed ID: 18187794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
